Clinical Trial Update: ET 50 for Post Caesarean Section Spinal Hypotension [Phase 2]

View source ↗

Summary

Phase 2 trial update of ET 50 for treating spinal hypotension after cesarean section; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension

Drugs mentioned

• ET 50

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Hypotension | Phase 2 | Status: COMPLETED